Shield
STX.LShield Therapeutics plc Price (STX.L)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
722,544,000
(209.8521)%Revenue and Profitability
| Year | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 304,000 | 637,000 | 11,881,000 | 719,000 | 10,387,000 | 1,519,000 | 4,467,000 | 13,085,000 |
| Net Income | -12,905,000 | -23,627,000 | -15,016,000 | -19,588,000 | -1,794,000 | -8,800,000 | -2,630,000 | -19,336,000 | -40,444,000 | -33,293,000 |
| FCF USD | -3,433,000 | -4,315,000 | -13,431,000 | -19,559,000 | -3,523,000 | -5,450,000 | -1,423,000 | -18,802,000 | -20,142,000 | -40,074,000 |
| OCF USD | -3,341,000 | -4,183,000 | -10,256,000 | -16,151,000 | -178,000 | -4,066,000 | -1,400,000 | -16,738,000 | -18,247,000 | -37,126,000 |
Financial Health - DEBT
| Year | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| YTPD | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.15 | -0.60 |
| D/E | -0.42 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.12 | 1.72 |
| CA/CL | 0.06 | 0.65 | 5.86 | 3.99 | 4.21 | 1.53 | 2.32 | 5.11 | 0.95 | 2.90 |
| TA/TL | 0.05 | 0.13 | 13.14 | 11.95 | 14.70 | 8.70 | 14.44 | 13.14 | 1.33 | 1.45 |
| Total Debt | 8,455,000 | 0 | 0 | 0 | 147,000 | 20,000 | 28,000 | 156,000 | 6,097,000 | 20,245,000 |
Management Performance
| Year | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROIC | -1,253.25% | 868.22% | -24.78% | -47.44% | -4.43% | -27.26% | -8.68% | -47.81% | -224.73% | -84.82% |
| ROE | 64.43% | 126.73% | -31.03% | -47.54% | -4.44% | -27.38% | -8.69% | -47.12% | -745.24% | -282.32% |
| ROA | 0.00% | -856.22% | -28.67% | -43.56% | -4.14% | -24.23% | -8.09% | -43.54% | -183.22% | -68.22% |
| NM % | - | - | -4,939.47% | -3,075.04% | -15.10% | -1,223.92% | -25.32% | -1,272.94% | -905.40% | -254.44% |
| FCF / R% | 0.00% | 0.00% | -4,418.09% | -3,070.49% | -29.65% | -758.00% | -13.70% | -1,237.79% | -450.91% | -306.26% |
| FCF / NI% | 25.56% | 17.62% | 89.44% | 99.85% | 196.38% | 61.93% | 54.11% | 97.24% | 49.80% | 120.37% |
| Operating Margin (OM) | - | - | -205.20 | -121.30 | -6.57 | -120.16 | -8.50 | -70.17 | -32.83 | -11.41 |
Per Share
| Year | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS | -0.39 | -0.55 | -0.14 | -0.17 | -0.01 | -0.07 | -0.02 | -0.09 | -0.17 | -0.05 |
| SPS | 0.00 | 0.00 | 0.00 | 0.01 | 0.10 | 0.01 | 0.09 | 0.01 | 0.02 | 0.02 |
| OCPS | -0.10 | -0.10 | -0.10 | -0.14 | 0.00 | -0.03 | -0.01 | -0.08 | -0.08 | -0.05 |
| FCPS | -0.10 | -0.10 | -0.13 | -0.17 | -0.03 | -0.05 | -0.01 | -0.09 | -0.09 | -0.06 |
| BVPS | -0.56 | -0.44 | 0.46 | 0.36 | 0.34 | 0.27 | 0.25 | 0.20 | 0.02 | 0.02 |
Per Share - CAGR
| Year | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| CAGR-EPS | -0.39 | -0.55 | -0.14 | -0.17 | -0.01 | -0.07 | -0.02 | -0.09 | -0.17 | -0.05 |
| CAGR-SPS | 0.00 | 0.00 | 0.00 | 0.01 | 0.10 | 0.01 | 0.09 | 0.01 | 0.02 | 0.02 |
| CAGR-OCPS | -0.10 | -0.10 | -0.10 | -0.14 | 0.00 | -0.03 | -0.01 | -0.08 | -0.08 | -0.05 |
| CAGR-FCPS | -0.10 | -0.10 | -0.13 | -0.17 | -0.03 | -0.05 | -0.01 | -0.09 | -0.09 | -0.06 |
| CAGR-BVPS | -0.56 | -0.44 | 0.46 | 0.36 | 0.34 | 0.27 | 0.25 | 0.20 | 0.02 | 0.02 |